US Patent 8187836 Mammalian expression vectors and uses thereof
Patent 8187836 was granted and assigned to Abbott on May, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+448 characters)
Article
Patent abstract
The present invention features nucleic acids for recombinant protein expression in mammalian cell culture. The episomal vectors of the invention promote high protein production in mammalian cells expressing the SV40 T Ag or Epstein-Barr virus nuclear antigen (e.g., COS7 or HEK293-6E cells). The methods and systems are useful, for example, in pharmaceutical drug development and cloning, especially for the production of antibodies.
Edits on 4 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Chung-ming Hsieh0
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08187836 Mammalian expression vectors and uses thereof US Patent 8187836 Mammalian expression vectors and uses thereof
Infobox
Patent Number
081878360
Patent Number
81878360
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
081878360
Date of Patent
May 29, 2012
0Patent Application Number
123545680
Date Filed
January 15, 2009
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08187836 Mammalian expression vectors and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08187836
Date of patent
May 29, 2012
Patent application number
12354568
Date Filed
January 15, 2009
Patent primary examiner
Find more entities like US Patent 8187836 Mammalian expression vectors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
